Fig. 1.
LPS, casein, and proinflammatory cytokines trigger dramatic increases in the synthesis of APR SAA in the liver by both translational and posttranslational mechanisms. The export of SAA from the liver may be inhibited by colchicine, a therapeutic for AA amyloid. SAA rapidly associates with HDL and has an ∼90-min half-life in the circulation.